Stemtech Statistics
Total Valuation
Stemtech has a market cap or net worth of 413,592. The enterprise value is 4.43 million.
| Market Cap | 413,592 |
| Enterprise Value | 4.43M |
Important Dates
The next estimated earnings date is Wednesday, August 19, 2026.
| Earnings Date | Aug 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Stemtech has 2.07 billion shares outstanding. The number of shares has increased by 43.07% in one year.
| Current Share Class | 2.07B |
| Shares Outstanding | 2.07B |
| Shares Change (YoY) | +43.07% |
| Shares Change (QoQ) | +52.54% |
| Owned by Insiders (%) | 1.48% |
| Owned by Institutions (%) | 0.01% |
| Float | 2.02B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.14 |
| PB Ratio | -0.05 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.10 |
| EV / Sales | 1.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04
| Current Ratio | 0.04 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.87 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -48.85% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 36.42% |
| Weighted Average Cost of Capital (WACC) | 22.60% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.83 |
| Inventory Turnover | 2.73 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.73% in the last 52 weeks. The beta is 2.64, so Stemtech's price volatility has been higher than the market average.
| Beta (5Y) | 2.64 |
| 52-Week Price Change | -99.73% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 43.10 |
| Average Volume (20 Days) | 16,281,274 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Stemtech had revenue of 2.88 million and -4.05 million in losses. Loss per share was -0.02.
| Revenue | 2.88M |
| Gross Profit | 2.31M |
| Operating Income | -2.71M |
| Pretax Income | -4.05M |
| Net Income | -4.05M |
| EBITDA | -2.54M |
| EBIT | -2.71M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 238,245 in cash and 5.01 million in debt, with a net cash position of -4.77 million or -0.00 per share.
| Cash & Cash Equivalents | 238,245 |
| Total Debt | 5.01M |
| Net Cash | -4.77M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -7.70M |
| Book Value Per Share | -0.02 |
| Working Capital | -10.13M |
Cash Flow
| Operating Cash Flow | -483,583 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 167,495 |
| Net Borrowing | 460,010 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 80.29%, with operating and profit margins of -94.18% and -140.69%.
| Gross Margin | 80.29% |
| Operating Margin | -94.18% |
| Pretax Margin | -140.80% |
| Profit Margin | -140.69% |
| EBITDA Margin | -88.36% |
| EBIT Margin | -94.18% |
| FCF Margin | n/a |
Dividends & Yields
Stemtech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -43.07% |
| Shareholder Yield | -43.07% |
| Earnings Yield | -978.43% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |